In this edition:
Intensive chemotherapy in the elderly for AML
TP53-independent activity of STING agonists against AML
Precision cancer research for Indigenous Australian cancer
Adaptive resistance to CAR T-cell therapy in B-ALL
Pharmacological binding site redirects transcription factor activity in AML
FLT3 signalling promotes tumour expansion and chemotherapy resistance in ALL
Cytokine and mutation profiling in CML
Informing therapeutic approaches for p53 defective cancers
Aspirin modifies the AEs of clonal haematopoiesis in elderly
Antibiotic-induced gut dysbiosis exacerbates ALL progression
Please login below to download this issue (PDF)